Showing results (2591-2600 of 3,087) with videos related to
Sort By:
Pageof 309
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 29, 2015
Mouse genome annotation by the RefSeq projectKelly M McGarvey, Tamara Goldfarb, Eric Cox, et al.BMJ Military Health|June 15, 2022
Addressing moral injury in the militaryAndrea J Phelps, A B Adler, S A H Belanger, et al.Biorxiv : the Preprint Server for Biology|June 9, 2023
Rapid and sensitive detection of genome contamination at scale with FCS-GXAlexander Astashyn, Eric S Tvedte, Deacon Sweeney, et al.Genome Biology and Evolution|March 9, 2016
Genome Sequencing of the Phytoseiid Predatory Mite Metaseiulus occidentalis Reveals Completely Atomized Hox Genes and Superdynamic Intron EvolutionMarjorie A Hoy, Robert M Waterhouse, Ke Wu, et al.Kidney International Reports|February 12, 2024
Clinicopathologic Features of Antibrush Border Antibody DiseaseJoel D Murphy, Tiffany N Caza, Clarissa A Cassol, et al.BMC Medical Research Methodology|August 15, 2022
Evaluation of data imputation strategies in complex, deeply-phenotyped data sets: the case of the EU-AIMS Longitudinal European Autism ProjectA Llera, M Brammer, B Oakley, et al.Stroke|June 10, 2006
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurementsB D Murphy, A J Fox, D H Lee, et al.Radiology|April 22, 2008
White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion studyBlake D Murphy, Allan J Fox, Donald H Lee, et al.Scientific Reports|November 29, 2012
Observation of inhibited electron-ion coupling in strongly heated graphiteT G White, J Vorberger, C R D Brown, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 9, 2024
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trialAlexander D Murphy, Catharine Porter, Ann White, et al.Pageof 309